Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol MDI in Acute Migraine
NCT00123201Phase 2Completed
- Sponsor
- Solvay
- Start
- Sep 2005
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dronabinol in migraine (4 arms), sponsored by Solvay. Primary endpoint: Proportion of subjects with pain response (mild or none) at 2 hours post-dose. Started Sep 2005; status: completed.
02
Drugs
dronabinol
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00123201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00123201.